Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_assertion type Assertion NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_head.
- NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_assertion description "[Also, we found that secreted factors overexpressed by anti-VEGF treatment-resistant pancreatic cancer cells acted in an autocrine manner to induce epithelial-to-mesenchymal transition (EMT) and were thus responsible for increased aggressiveness of bevacizumab-resistant pancreatic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_provenance.
- NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_assertion evidence source_evidence_literature NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_provenance.
- NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_assertion SIO_000772 21737511 NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_provenance.
- NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_assertion wasDerivedFrom befree-20140225 NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_provenance.
- NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_assertion wasGeneratedBy ECO_0000203 NP335290.RAcIqoL77NxPBuM8abbRSo6L9UOJtwO6-U60KbTjf7kmE130_provenance.